Moderna Stock Price on April 26, 2024

MRNA Stock  USD 125.63  2.69  2.10%   
Below is the normalized historical share price chart for Moderna extending back to December 07, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Moderna stands at 125.63, as last reported on the 15th of May 2024, with the highest price reaching 125.63 and the lowest price hitting 125.63 during the day.
IPO Date
7th of December 2018
200 Day MA
98.4681
50 Day MA
108.6754
Beta
1.565
 
Covid
If you're considering investing in Moderna Stock, it is important to understand the factors that can impact its price. Moderna appears to be very steady, given 3 months investment horizon. Moderna has Sharpe Ratio of 0.16, which conveys that the firm had a 0.16% return per unit of risk over the last 3 months. By analyzing Moderna's technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please exercise Moderna's Downside Deviation of 2.53, mean deviation of 2.51, and Risk Adjusted Performance of 0.12 to check out if our risk estimates are consistent with your expectations.
  
At present, Moderna's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 320.2 M, whereas Common Stock is projected to grow to (732.7 M). . The current year's Price Earnings To Growth Ratio is expected to grow to 0.05, whereas Price To Sales Ratio is forecasted to decline to 5.34. Moderna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1606

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsMRNA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.55
  actual daily
31
69% of assets are more volatile

Expected Return

 0.57
  actual daily
11
89% of assets have higher returns

Risk-Adjusted Return

 0.16
  actual daily
12
88% of assets perform better
Based on monthly moving average Moderna is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Moderna by adding it to a well-diversified portfolio.
Price Book
2.9071
Enterprise Value Ebitda
(10.03)
Price Sales
5.8785
Shares Float
346 M
Wall Street Target Price
138.52

Related Headline

Beam TherapeuticsInc Headline on 26th of April 2024

Filed transaction by Beam TherapeuticsInc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Moderna Valuation on April 26, 2024

It is possible to determine the worth of Moderna on a given historical date. On April 26, 2024 Moderna was worth 106.18 at the beginning of the trading date compared to the closed value of 107.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Moderna stock. Still, in general, we apply an absolute valuation method to find Moderna's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Moderna where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Moderna's related companies.
 Open High Low Close Volume
  107.43    108.23    103.52    106.18    2,797,354  
04/26/2024
  106.18    108.19    105.39    107.97    2,239,372  
  108.78    112.33    108.72    111.62    2,607,000  
Backtest Moderna  |  Moderna History  |  Moderna Valuation   PreviousNext  
Open Value
106.18
107.97
Closing Value
116.84
Upside

Moderna Trading Date Momentum on April 26, 2024

On April 29 2024 Moderna was traded for  111.62  at the closing time. The top price for the day was 112.33  and the lowest listed price was  108.72 . The trading volume for the day was 2.6 M. The trading history from April 29, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 3.38% . The trading delta at closing time against the current closing price is 15.77% .

Moderna Fundamentals Correlations and Trends

By evaluating Moderna's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Moderna's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Moderna financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Moderna Stock history

Moderna investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Moderna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Moderna will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Moderna stock prices may prove useful in developing a viable investing in Moderna
Last ReportedProjected for Next Year
Common Stock Shares Outstanding382 M346.5 M
Net Income Applicable To Common Shares9.6 B10.1 B

Moderna Quarterly Net Working Capital

7.22 Billion

Moderna Stock Technical Analysis

Moderna technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Moderna technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Moderna trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Moderna Period Price Range

Low
April 26, 2024
1.79  1.69%
High

 106.18 

     

 107.97 

Moderna May 15, 2024 Market Strength

Market strength indicators help investors to evaluate how Moderna stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Moderna shares will generate the highest return on investment. By undertsting and applying Moderna stock market strength indicators, traders can identify Moderna entry and exit signals to maximize returns

Moderna Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Moderna's price direction in advance. Along with the technical and fundamental analysis of Moderna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Moderna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.85)
Earnings Share
(15.60)
Revenue Per Share
13.525
Quarterly Revenue Growth
(0.91)
Return On Assets
(0.16)
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.